Biotech company Enterin has announced the results of their phase 2 clinical trial of ENT-01 indicating that it had a positive benefit on the gut symptoms associated with Parkinson’s.
Researchers have reported that the ability of gut bacteria to break down fat is disrupted in people with Parkinson’s, resulting in issues with the production of bile acid.
Researchers in Stockholm have recently published a report indicating that the removal of the appendix or tonsils could reduce a person’s risk of developing Parkinson’s.
A new study published in the journal ‘Neuron’ has found more evidence that Parkinson’s starts in the gut
Although its exact role isn’t yet clear because findings have been conflicting, in this easy-to-read overview the link between the appendix in the gut and risk of developing Parkinson’s…